| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $16.1M | — | +5.6% |
| Cost of Revenue | $9.1M | — | +13.3% |
| Gross Profit | $5.9M | — | -9.9% |
| R&D Expense | $214K | — | -40.5% |
| SG&A Expense | $7.5M | — | +8.2% |
| Operating Income | -$1.8M | — | -141.9% |
| Pre-tax Income | -$2.0M | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $22.7M | +30.7% | -7.5% |
| Accounts Receivable | $6.3M | -16.0% | +6.5% |
| Current Assets | $46.6M | +0.6% | +0.1% |
| Total Assets | $62.6M | +0.3% | -0.3% |
| Current Liabilities | $21.7M | +9.9% | -3.2% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $5.3M | — | -3.9% |
| Capital Expenditures | $485K | — | +381.7% |
| Investing Cash Flow | -$443K | — | -308.0% |
| Financing Cash Flow | $191K | — | +24.8% |
| Free Cash Flow | $4.8M | — | -11.1% |
| -547.3% |
| Income Tax | $216K | — | -6.1% |
| Net Income | -$2.4M | — | -3429.7% |
| EPS (Basic) | -$0.20 | — | -3433.3% |
| EPS (Diluted) | -$0.20 | — | -3433.3% |
| $204K |
| +166.1% |
| +355.7% |
| Total Liabilities | $22.1M | +9.5% | -4.2% |
| Stockholders' Equity | $35.8M | -5.4% | +3.1% |